Pediatric Multiple Sclerosis in Tunisia: A Retrospective Study over 11 Years

Area of Science:

• Neurology
• Pediatrics
• Immunology

Background:

• Pediatric multiple sclerosis (pMS) is a rare autoimmune demyelinating disease affecting individuals under 18.
• Characterizing pMS in specific pediatric populations is crucial for understanding disease heterogeneity.

Purpose of the Study:

• To investigate the epidemiological, clinical, and therapeutic characteristics of pediatric multiple sclerosis in Tunisian children.
• To identify unique features of pMS within the Tunisian pediatric cohort.

Main Methods:

• A retrospective study was conducted over 11 years (2005-2016) involving pediatric patients diagnosed with pMS.
• Data collected included epidemiological, clinical, neuroimaging, laboratory, and therapeutic information, analyzed according to the 2012 International Pediatric Multiple Sclerosis Study Group criteria.

Main Results:

• The study included 21 patients (male-female ratio 1:3) with a mean age of onset of 11 years.
• Polyfocal presentation (81%) and motor dysfunction (57%) were common, with 24% experiencing paroxysmal dystonia. Three patients had type 1 diabetes.
• All patients presented with the relapsing-remitting form; 80% received interferon beta, showing a reduced annual relapse rate.

Conclusions:

• The estimated annual incidence of pMS in Tunisian children is 0.05 per 100,000.
• Notable features in this cohort include a frequent association with type 1 diabetes and increased dystonia occurrence.
• Enhanced awareness of pMS is essential for optimizing management strategies for affected children and their families.